Latest News for: small molecule

Edit

Inside Amgen’s Next-Generation Labs: Powering Faster, Smarter Small Molecule Drug Discovery (Amgen Inc)

Public Technologies 06 May 2026
... approach helps teams learn faster, optimize molecules with greater precision, and move potential medicines forward for patients [...].
Edit

Global RNA Targeting Small Molecule Drug Discovery Market Size/Share Worth USD 17.6 Billion by 2035 ...

Nasdaq Globe Newswire 06 May 2026
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global RNA Targeting Small Molecule Drug Discovery Market size & share ...
Edit

Oral small-molecule GLP-1 drugs penetrate deep into the brain to suppress cravings (NIH - National Institutes of Health)

Public Technologies 06 May 2026
Wednesday, May 6, 2026 Oral small-molecule GLP-1 drugs penetrate deep into the brain to suppress cravings ... Until now, scientists have had a much less firm grasp on how small-molecule GLP-1 drugs work.
Edit

FDA Grants Fast Track Designation for CS-1103, a First-in-class Small Molecule to Reverse Acute Intoxication from Fentanyl

PR Newswire 05 May 2026
... Scientific is focused on the development of first-in-class small molecules to reverse acute intoxication from drugs of abuse and accelerate their clearance from the body, preventing further harm.
Edit

Small Molecule Innovator CDMO Research Report 2026: $93.12 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, ...

Nasdaq Globe Newswire 29 Apr 2026
Key opportunities in the small molecule innovator CDMO market include rising outsourcing by biotech firms, demand for ...
Edit

Lantern Pharma’s predictBBB.ai Evolves Into a Real-Time Large Quantitative Model (LQM) for Precision Molecular Intelligence — Comprehensive Small Molecule Characterization & Development Analytics Available as a Web Service to Drug Developers Globally (Lantern Pharma Inc)

Public Technologies 29 Apr 2026
By submitting a single SMILES string, users receive a comprehensive, 360-degree developability profile of any small molecule in seconds ... A Universal Engine for All of Small-Molecule Drug Discovery.
Edit

Context-dependent variability of HIF heterodimers influences interactions with macromolecular and small molecule partners

PNAS 28 Apr 2026
.
Edit

Small Molecule API Market to Reach USD 202.53 Billion by 2036, Driven by Generic Drug Demand and Expanding Oncology Pipeline

PR Newswire 28 Apr 2026
Small Molecule-Drug Conjugates Market.https.//www.futuremarketinsights.com/reports/small-molecule-drug-conjugates-market. Small Molecule Innovator CDMO Market.https.//www.futuremarketinsights.com/reports/small-molecule-innovator-cdmo-market.
Edit

Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R ...

Killeen Daily Herald 27 Apr 2026
HONG KONG, April 26, 2026 ....
Edit

Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes

PR Newswire 27 Apr 2026
Utilizing its proprietary Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies as well as Peptide Oral Transport ENhancement ...
Edit

Fathom Therapeutics, Formerly Atommap, Raises $47 Million in Oversubscribed Series A Financing to Translate Physics and AI-Enabled Small Molecule Design into Next-Generation Medicines

PR Newswire 27 Apr 2026
The simulations, based on physics, enable generative design of small molecules that reshape protein behavior for the desired therapeutic effect ... classes of targets and small molecule modalities.
Edit

Exhibit 47 - Newman From Powders to Single Crystals A Crystallographers Toolbox for Small-Molecule Structure Determination (The eRulemaking Program)

Public Technologies 21 Apr 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 131089008) .
Edit

Remix Therapeutics Announces Oral Presentation of First-in-Class Small Molecule MYB mRNA Degrader REM-422 Phase 1/2 ...

Nasdaq Globe Newswire 21 Apr 2026
Results of Phase 1 Dose-Escalation Cohort Including Antitumor Activity and Safety of REM-422 in Adenoid Cystic Carcinoma. Results of Phase 1 Dose-Escalation Cohort Including Antitumor Activity and Safety of REM-422 in Adenoid Cystic Carcinoma ... .
Edit

SynSmart and Amporin Announce Collaboration to Develop Breakthrough Small Molecule Therapeutics for Degenerative Diseases

The Hindu 20 Apr 2026
Basel, Switzerland & Mumbai, Maharashtra, India --- Business Wire India ....
Edit

Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R ...

Nasdaq Globe Newswire 13 Apr 2026
Trial Designed to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SEP-479 in Healthy Volunteers ... .

Article Search

tools
×
×
×
×